Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Illumina, Inc.    ILMN   US4523271090

ILLUMINA, INC. (ILMN)

58
Delayed Quote. Delayed Nasdaq - 11/26 04:00:00 pm
191.9 USD   +1.42%
11/20 ILLUMINA : U.S. Agency Forges Partnership to Curb Ebola
11/19 ILLUMINA : USAID, Broad Institute and Illumina Form a Public-Private Partne..
11/18 NASDAQ 100 MOVERS : Spls, ilmn
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/20/2014 11/21/2014 11/24/2014 11/25/2014 11/26/2014 Date
186.26(c) 185.83(c) 191.16(c) 189.21(c) 191.9(c) Last
900 748 796 350 903 059 1 604 191 656 128 Volume
-1.98% -0.23% +2.87% -1.02% +1.42% Change
More quotes
Company
Illumina, Inc. develops, manufactures and markets life science tools and integrated systems for the analysis of genetic variation and function.The company provides sequencing and array-based solutions for genotyping, copy-number variation analysis, methylation studies and gene expression profiling... 
Surperformance© rating of Illumina, Inc.
Trading Rating : Investor Rating :
More about the company
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 1 855 M
EBIT 2014 532 M
Net income 2014 296 M
Debt 2014 602 M
Yield 2014 -
Sales 2015 2 266 M
EBIT 2015 662 M
Net income 2015 391 M
Finance 2015 496 M
Yield 2015 -
PER 2014 96,01
PER 2015 71,81
EV / Sales 2014 15,0x
EV / Sales 2015 11,8x
Capitalization 27 250 M
More Financials
Latest news on ILLUMINA, INC.
2d ago ILLUMINA : USAID, Broad Institute and Illumina Form a Public-Private Partnership..
4d ago ILLUMINA : US agency forges partnership to curb Ebola
4d ago ILLUMINA : USAID, Broad Institute and Illumina Team to Combat Ebola
6d ago ILLUMINA : bioMerieux and Illumina Reach Agreement
11/20 ILLUMINA : Modification to a Previous Presolicitation Notice - 66-- Notice of In..
11/20 ILLUMINA : USAID, Broad Institute and Illumina Form a Public-Private Partnership..
11/20 ILLUMINA : U.S. Agency Forges Partnership to Curb Ebola
11/19 ILLUMINA : Researchers Submit Patent Application, "Patterned Flow-Cells Useful f..
11/19 ILLUMINA : Patent Issued for Formylpyrrole-Based Heterocycles for Nucleic Acid A..
11/19 ILLUMINA : Patent Issued for Confocal Imaging Methods and Apparatus
11/19 ILLUMINA : USAID, Broad Institute and Illumina Form a Public-Private Partnership..
11/18 NASDAQ 100 MOVERS : Spls, ilmn
More news
4-Traders Strategies on ILLUMINA, INC. 
2013End of the technical recovery
More Strategies


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF